Quote:

---

Melon Troy was moderate, and she was discharged after just a handful of days...

---

You are a mind reader.

She is precisely the reason why I posted that message.

The design of our CD10 M/M protocol prevents many types of recovery metrics from being adequately documented.

More specifically, the protocol design prevents the intermediate values of these endpoints from being known in any less than a 14 day interval:

- Incidence of hospitalization [ Time Frame: Day 14 ]
- Duration (days) of hospitalization [ Time Frame: Day 14 ]
- Incidence of mechanical ventilation supply [ Time Frame: Day 14 ]
- Duration (days) of mechanical ventilation supply [ Time Frame: Day 14 ]
- Incidence of oxygen use [ Time Frame: Day 14 ]
- Duration (days) of oxygen use [ Time Frame: Day 14 ]
- Mortality rate [ Time Frame: Day 14 ]
- Time to return to normal activity [ Time Frame: Day 14 ]
- Change in size of lesion area by chest radiograph or CT [ Time Frame: Day 14 ]

This design flaw undermines our ability to tell the entire miraculous story of what our molecule is capable of doing in a very short amount of time.

I could be overreacting, but this is really disappointing.